CASI - CASI Pharmaceuticals GAAP EPS of -$2.02 revenue of $33.88M
2024-03-28 07:22:06 ET
More on CASI Pharmaceuticals
- CASI stock rises on positive interim data from early stage trial for its NHL treatment in China
- Seeking Alpha’s Quant Rating on CASI Pharmaceuticals
- Historical earnings data for CASI Pharmaceuticals
- Financial information for CASI Pharmaceuticals